Volume 8, Issue 1 (2022)                   Pharm Biomed Res 2022, 8(1): 87-90 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bhatia A R, Saxena A, Tyagi N, Bagra P, Bhatia P. Moderna (mRNA Vaccine) for COVID-19: A Leap in Vaccine World. Pharm Biomed Res 2022; 8 (1) :87-90
URL: http://pbr.mazums.ac.ir/article-1-406-en.html
1- Department of Clinical Biochemistry, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
2- Department of Biochemistry, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
3- Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, India.
Abstract:   (1514 Views)
In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) appeared and spread worldwide, triggering a pandemic of respiratory illness. So, there was an urgent need for vaccines worldwide. The mRNA-based vaccines are undergoing an accelerated phase of development during this pandemic. WHO has issued interim guidelines for administering the Moderna mRNA-1273 vaccine against COVID-19 based on advice given by the Strategic Advisory Group of Experts on Immunization (SAGE). The significant future directions for study would be comparing and elucidating the immune processes triggered by mRNA vaccine platforms, developing existing methods focused on these mechanisms, and introducing new clinical trials of these vaccines against additional disease targets.
This study aims to reveal the important role and contribution of the Moderna mRNA-1273 vaccine to COVID-19 vaccinology. 
Moderna mRNA-1273 vaccine could be the keystone of modern vaccinology in the context of the COVID-19 pandemic.
Keywords: Moderna, Vaccine, COVID-19
Full-Text [PDF 402 kb]   (953 Downloads) |   |   Full-Text (HTML)  (874 Views)  
Type of Study: Short Communication | Subject: Immunology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb